An interventional study of Expressive writing in Colorectal Cancer, sponsored by Temple University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-08-02.
Sponsored by Temple University · Not applicable, Interventional, and Supportive care
The purpose of the study is to find new ways to improve the quality of life of people who have been treated for colon or rectal cancer.
Individuals who take part in the study can expect:
Two Interviews:
Brief Writing in a Journal:
5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.
This study's enrollment of 193 is above the median of 77 across 4,123 interventional studies indexed under Colorectal Neoplasms.
Browse Colorectal Neoplasms studies →Temple University is the lead sponsor of 219 studies on the registry; 30 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 7 (58%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Writing in a journal 15 minutes a day
Behavioral: Expressive writing
Control Writing in a journal 15 minutes a day
Behavioral: Expressive writing
Behavioral intervention using writing about cancer to improve quality of life outcomes
Depressive symptoms
self-report depressive symptoms
Time frame: 2-Weeks
This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Temple University